Biolase (BIOL) Appoints Kenneth P. Yale to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
BIOLASE STRENGTHENS ITS BOARD OF DIRECTORS WITH ADDITION OF SEASONED HEALTHCARE EXECUTIVE
May 9, 2022 6:30 AM EDTFOOTHILL RANCH, Calif., May 9, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that Kenneth P. Yale, D.D.S., J.D. was newly elected to its Board of Directors (the "Board"), effective April 28, 2022. Dr. Yale, along with other recently elected Board members, Drs. Kathleen T. O'Loughlin, Carol Gomez Summerhays, and Martha Somerman, will provide insight and support the implementation of the Company's business plan, which has demonstrated significant growth over the past several quarters.
... More